Previous Article | Next Article ![]()
Journal of Virology, September 1998, p. 7237-7244, Vol. 72, No. 9
Department of Microbiology, University of
Colorado Health Sciences Center, Denver, Colorado
80262,1 and
Department of Pathology,
Uniformed Services University of the Health Sciences, Bethesda,
Maryland 208142
Received 20 February 1998/Accepted 28 May 1998
Mouse hepatitis virus receptor (MHVR) is a murine biliary
glycoprotein (Bgp1a). Purified, soluble MHVR expressed from
a recombinant vaccinia virus neutralized the infectivity of the A59
strain of mouse hepatitis virus (MHV-A59) in a concentration-dependent
manner. Several anchored murine Bgps in addition to MHVR can also
function as MHV-A59 receptors when expressed at high levels in
nonmurine cells. To investigate the interactions of these alternative
MHVR glycoproteins with MHV, we expressed and purified to apparent
homogeneity the extracellular domains of several murine Bgps as
soluble, six-histidine-tagged glycoproteins, using a baculovirus
expression system. These include MHVR isoforms containing four or two
extracellular domains and the corresponding Bgp1b
glycoproteins from MHV-resistant SJL/J mice, as well as Bgp2 and
truncation mutants of MHVR and Bgp1b comprised of the first
two immunoglobulin-like domains. The soluble four-domain MHVR
glycoprotein (sMHVR[1-4]) had fourfold more MHV-A59 neutralizing
activity than the corresponding soluble Bgp1b
(sBgp1b) glycoprotein and at least 1,000-fold more
neutralizing activity than sBgp2. Although virus binds to the
N-terminal domain (domain 1), soluble truncation mutants of MHVR and
Bgp1b containing only domains 1 and 2 bound virus poorly
and had 10- and 300-fold less MHV-A59 neutralizing activity than the
corresponding four-domain glycoproteins. In contrast, the soluble MHVR
glycoprotein containing domains 1 and 4 (sMHVR[1,4]) had as much
neutralizing activity as the four-domain glycoprotein, sMHVR[1-4].
Thus, the virus neutralizing activity of MHVR domain 1 appears to be
enhanced by domain 4. The sBgp1b[1-4] glycoprotein had
500-fold less neutralizing activity for MHV-JHM than for MHV-A59. Thus,
MHV strains with differences in S-glycoprotein sequence, tissue
tropism, and virulence can differ in the ability to utilize the various
murine Bgps as receptors.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Purified, Soluble Recombinant Mouse Hepatitis Virus Receptor,
Bgp1b, and Bgp2 Murine Coronavirus Receptors Differ in
Mouse Hepatitis Virus Binding and Neutralizing Activities


*
Corresponding author. Mailing address: Department of
Microbiology, Campus Box B-175, University of Colorado Health Sciences Center, 4200 East 9th Ave., Denver, CO 80262. Phone: (303) 315-7329. Fax: (303) 315-6785. E-mail: kathryn.holmes{at}uchsc.edu.
Present address: Medical Virology Section, Laboratory of Clinical
Investigation, NIAID, NIH, Bethesda, MD 20892.
Present address: Genetic Therapy Inc., Gaithersburg, MD 20878.
§
Present address: H. M. Jackson Foundation, AFRIMS,
Bangkok, Thailand.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|